PD-L1 (CD274) Human Monoclonal Antibody [Clone ID: OTI8C8]
CAT#: CF813015
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
Formulation: Standard
View other "OTI8C8" antibodies (4)
Need it in bulk or conjugated?
Get a free quote
CNY 3,999.00
Specifications
Product Data | |
Clone Name | OTI8C8 |
Applications | FC |
Recommend Dilution | FLOW 1:50~100 |
Reactivity | Human |
Host | Human |
Clonality | Monoclonal |
Formulation | Lyophilized powder (original buffer 1X PBS, pH 7.3, 8% trehalose) |
Reconstitution Method | For reconstitution, we recommend adding 100uL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiment, we strongly recommend performing another round of desalting process. (OriGene recommends Zeba Spin Desalting Columns, 7KMWCO from Thermo Scientific) |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 33.28 kDa |
Gene Name | CD274 molecule |
Database Link | |
Background | This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015] |
Synonyms | B7-H; B7H1; hPD-L1; PD-L1; PDCD1L1; PDCD1LG1; PDL1 |
Reference Data | |
Protein Families | Druggable Genome, Transmembrane |
Protein Pathways | Cell adhesion molecules (CAMs) |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
TA813015 | A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence |
CNY 1,999.00 |
|
TA813015AM | A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence, Biotinylated |
CNY 3,990.00 |
|
TA813015BM | A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence, HRP conjugated |
CNY 3,990.00 |
|
TA813015S | A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence |
CNY 800.00 |